Anemia, Sickle Cell: all 1,125 studies
Page 1 of 12. Open to participants first (239), then studies with results posted, then the rest; newest registration first within each.
- MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT)Not yet recruitingNCT07892651
- Self-administered Acupressure in Patients With Sickle Cell DiseaseNot yet recruitingNCT07875777Not applicable
- Inflammatory Markers and Pain in Sickle Cell DiseaseNot yet recruitingNCT07865039
- Comparison of Thrombin Generation, Platelet Activation and Aggregation Profiles in Patients With Sickle Cell Disease Depending on Their SS or SC Genotype (DrepAgreg)Not yet recruitingNCT07852442
- Adaptive Platform Trial for Pain Management in Sickle Cell Vaso-Occlusive CrisisNot yet recruitingNCT07826988Phase 4
- Effectiveness of Innovative Educational Methods in Empowering Children With Sickle Cell DiseaseNot yet recruitingNCT07802210Not applicable
- Hemoglobin Disorders in Egypt: Sickle Cell Disease Ain Shams University Institutional RegistryRecruitingNCT07800247
- Buprenorphine for the Management of Pain in Children With Sickle Cell DiseaseNot yet recruitingNCT07799571Phase 1
- MBI for Pain and Sleep in Adolescents and Young Adults With Sickle Cell DiseaseNot yet recruitingNCT07797582Not applicable
- Pleuropulmonary Ultrasound Imaging in Patients With Sickle Cell Disease in a Vaso-occlusive Crisis. "ECHODREP"Not yet recruitingNCT07782489
- Cerebrovascular Reactivity Measurements With High-Density Diffuse Optical TomographyRecruitingNCT07776444Not applicable
- Domestication and Implementation of the PEN-Plus Clinical Model in the Zambian Health SystemRecruitingNCT07753681
- Standard of Care Comparative Arm of Phase 1/2 Gene Therapy Trial DREPAMIR" in Severe Sickle Cell Disease PatientsNot yet recruitingNCT07752043Not applicable
- Universal Newborn Screening For Sickle Cell Disease In MozambiqueNot yet recruitingNCT07719972Not applicable
- Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) StudyRecruitingNCT07708714Phase 1/2
- Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Sickle Cell DiseaseRecruitingNCT07708350Phase 1
- CPAP for Hypoxemic Acute Chest Syndrome in Sickle Cell DiseaseNot yet recruitingNCT07703566Not applicable
- Low Dose Bolus Ketamine For Use In Sickle Cell Pain CrisisNot yet recruitingNCT07682662Phase 4
- Virtual Reality for SCD VOCRecruitingNCT07674277Not applicable
- A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)RecruitingNCT07656415Phase 3
- Feasibility and Acceptability of AmaniNot yet recruitingNCT07648043Phase 1/2
- Epidemiology of Invasive Bacterial Infections in Children With Sickle Cell Disease in France Between 2020 and 2025Not yet recruitingNCT07639008
- Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell DiseaseRecruitingNCT07616154Phase 2
- Evaluation of an Information Management and Communication System for Population-wide Point-of-Care Infant Sickle Cell Disease ScreeningRecruitingNCT07610239Not applicable
- Partial Stem Cell Transplant for Sickle Cell Disease From Matched DonorsRecruitingNCT07599176Phase 1/2
- Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell DiseaseRecruitingNCT07566494Phase 1
- Assessing Molecular Mechanisms and Effects of Music Therapy in Youth With Sickle Cell Disease Using Single-cell RNA-sequencingRecruitingNCT07562451Not applicable
- Hydroxyurea Optimisation in Sickle Cell DiseaseNot yet recruitingNCT07543289
- Development of a Provider-Focused Intervention to Improve Health Outcomes in Pediatric Sickle Cell DiseaseNot yet recruitingNCT07540767Not applicable
- Omega-3-Fatty Acids in Children With Sickle Cell DiseaseNot yet recruitingNCT07530965Not applicable
- Evaluation of the Efficacy of Iloprost in the Management of Vaso-occlusive Crises in Adult Patients With Sickle Cell DiseaseNot yet recruitingNCT07498309Phase 3
- Integrating Point of Care Testing (POCT) For Newborn Screening and Early Care for Sickle Cell Disease in Yopougon, Côte d'IvoireRecruitingNCT07488520Phase 4
- Multi Disciplinary Sickle Cell Disease Obstetrics Care Program in GhanaRecruitingNCT07488091Not applicable
- Optimal Timing of Ketamine Initiation for SCD PainNot yet recruitingNCT07450430Phase 3
- SickleFit Exercise and Nutrition StudyRecruitingNCT07442851Not applicable
- Safety and Efficacy of KL003 Cell Injection in Severe Sickle Cell DiseaseNot yet recruitingNCT07436767Not applicable
- Efficacy Safety Study of Gene Therapy for Sickle Cell DiseaseSCD Using Autologous CD34+ Cells Transduced ex Vivo, Carrying a Corrected Globin Gene and a Silencing RNA.RecruitingNCT07432867Phase 1/2
- Open-Label Extension Study to Pioneer Study 6058-SCD-101Enrolling by invitationNCT07401823Phase 2
- Functional Ovarian Reserve in Sickle Cell DiseaseRecruitingNCT07392216
- A Long-term Follow-up Study in Patients Who Received BEAM-101RecruitingNCT07373639
- Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young AdultsRecruitingNCT07369024Phase 2
- Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell DiseaseRecruitingNCT07356050
- STEM CELL MOBILIZATION WITH HIGH-DOSE PLERIXAFOR IN PATIENTS WITH SICKLE CELL DISEASENot yet recruitingNCT07341022Phase 1/2
- Stress Management and Mindfulness Intervention for Patients With Sickle Cell DiseaseRecruitingNCT07316478Not applicable
- Efficacy and Safety of SIL-8301 for Control of Hemolysis in a Uniform Sickle Cell Disease EndotypeRecruitingNCT07282210Phase 2
- Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell DiseaseRecruitingNCT07274254Phase 3
- Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell DiseaseRecruitingNCT07252050Phase 1/2
- Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell DiseaseRecruitingNCT07247188Phase 3
- Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive CareRecruitingNCT07246265Not applicable
- Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell DiseaseRecruitingNCT07226219Phase 1
- Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)RecruitingNCT07224360Phase 2
- Writing Relaxing Beats in Adolescents Who Have Sickle Cell DiseaseRecruitingNCT07222475Not applicable
- Integrative Diagnosis for SCD and Other RADsRecruitingNCT07206095
- Outcomes of Vaso-occlusive Crisis in Pediatric Sickle Cell DiseaseNot yet recruitingNCT07200869
- YOLT-204 in Patients With HemoglobinopathiesNot yet recruitingNCT07190001Early Phase 1
- Efficacy of Liberal Versus Restricted IV Fluid Approach in the Management of Sickle Cell Vaso-Occlusive CrisisRecruitingNCT07188766Not applicable
- A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)RecruitingNCT07187973Phase 1
- Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations (ENHANCE)RecruitingNCT07177300Phase 4
- Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, EmpagliflozinRecruitingNCT07175051Phase 2
- Transfusion Exchanges and Cognition in Sickle Cell DiseaseNot yet recruitingNCT07168447
- HPC Offered for PRESERVE ExpansionRecruitingNCT07145411
- Serial Assessment of Fertility ExperiencesRecruitingNCT07116772
- Trans-auricular Nerve Stimulation as an Innovative Approach to the Treatment of Pain in Pediatric Patients Suffering From Sickle Cell DiseaseRecruitingNCT07090668Not applicable
- Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell TraitRecruitingNCT07083531
- Sickle Cell Kidney BiorepositoryRecruitingNCT07064174
- Early Screening and Treatment of Heart Complication in Sickle Cell DiseaseRecruitingNCT07023666Phase 2
- 131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)RecruitingNCT07015684Phase 1
- Effect of EMDR for Reduction of Pain Interference in Children With Sickle Cell DiseaseRecruitingNCT07001631Not applicable
- Impact of Regional Anesthesia on Inflammatory Mechanisms During Vaso-occlusive Crisis in Sickle Cell PatientsRecruitingNCT07001189
- Molecular and Cellular Basis of Severe Forms of Dengue in Sickle Cell PatientsRecruitingNCT07000747
- CS-206 in Patients With Sickle Cell DiseaseNot yet recruitingNCT07000318Early Phase 1
- A Study of Intravenous L-Citrulline in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive CrisisNot yet recruitingNCT06989567Phase 3
- The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell DiseaseRecruitingNCT06975865Phase 3
- Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell DiseaseRecruitingNCT06944067
- Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell DiseaseRecruitingNCT06941389
- Cannabidiol in Sickle Cell DiseaseRecruitingNCT06930703Phase 1/2
- PASS of Xromi Comparing Safety and Effectiveness in Children Under 2 Years With Sickle Cell Disease [PRECISE PASS]RecruitingNCT06923111
- Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell DiseaseRecruitingNCT06919224Not applicable
- Phenotypic and Transcriptomic Description of Megakaryocytes in Sickle Cell PatientRecruitingNCT06887907
- Allo HSCT for High Risk HemoglobinopathiesRecruitingNCT06872333Phase 2
- MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell DiseaseRecruitingNCT06853158Not applicable
- Megakaryocyte Heterogeneity in Sickle Cell DiseaseNot yet recruitingNCT06850337
- Long-term Endurance Training in Sickle Cell Disease Patients: Impact on Clinical Profile, Physical Fitness, and Quality of Life.RecruitingNCT06823219Not applicable
- ATHNdataset RegistryRecruitingNCT06820515
- Efficacy and Safety of Tocilizumab for Acute Chest Syndrome Treatment in Patients With Sickle Cell DiseaseRecruitingNCT06818266Phase 3
- Transcranial Photobiomodulation Treatment in Patients With Sickle Cell DiseaseNot yet recruitingNCT06797583Not applicable
- Virtual Reality As Adjunct Therapy for Vaso-Occlusive PainRecruitingNCT06773715Not applicable
- Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell DiseaseRecruitingNCT06770010Not applicable
- Evaluation of the Impact of Red Blood Cell Exchange on Thrombo-inflammation in Sickle Cell DiseaseNot yet recruitingNCT06769139
- Optimizing Hydroxyurea Dosage With Pharmakokinetic in Patients Suffering of Moderate to Severe Sickle Cell AnemiaRecruitingNCT06761560Phase 2/3
- Pulmonary Functions in Sickle Cell Disease: Response to Acu-TENSRecruitingNCT06757829Not applicable
- Pilot Study on the Value of Bedside Pleuropulmonary Ultrasound in Patients With Sickle Cell Disease Presenting With Vaso-occlusive CrisisNot yet recruitingNCT06755385
- Hypoxic Red Blood Cells in Sickle Cell AnemiaNot yet recruitingNCT06743113Not applicable
- Pilot Study "AHSP as a Biomarker of Sickle Cell Disease in a Population of Adults and Children"RecruitingNCT06735625Not applicable
- Expanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell BoostsAvailableNCT06731036
- Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0RecruitingNCT06725550Not applicable
- Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive CrisisRecruitingNCT06699849Phase 2
- Awake Prone Positioning for Severe Acute Chest SyndromeNot yet recruitingNCT06698120Not applicable
- Integrative Training Program for Pediatric Sickle Cell PainRecruitingNCT06691867Not applicable
- Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular TherapyRecruitingNCT06689800Not applicable